Lukáš Moráň

Lukáš Moráň

Auto-generated profile, based on publicly available information

Lukáš Moráň

Department of Histology and Embryology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2021 in Molecules
Verified
Journal Article
Open access
PDF file
SMSebastiano Masuri
Sebastiano Masuri
PVPetr Vanhara
Petr Vanhara
MCMaria Grazia Cabiddu
Maria Grazia Cabiddu
LMLukáš Moráň
Lukáš Moráň
JHJosef Havel
Josef Havel
TPTiziana Pivetta
Tiziana Pivetta
Copper is an endogenous metal ion that has been studied to prepare a new antitumoral agent with less side-effects. Copper is involved as a cofactor in several enzymes, in ROS production, in the promotion of tumor progression, metastasis, and angiogenesis, and has been found at high levels in serum and tissues of several types of human cancers. Under these circumstances, two strategies are commonly followed in the development of novel anticancer Copper-based drugs: the sequestration of free Copper ions and the synthesis of Copper complexes that trigger cell death. The latter strategy has been followed in the last 40 years and many reviews have covered the anticancer properties of a broad spectrum of Copper complexes, showing that the activity of these compounds is often multi factored. In this work, we would like to focus on the anticancer properties of mixed Cu(II) complexes bearing substituted or unsubstituted 1,10-phenanthroline based ligands and different classes of inorganic and organic auxiliary ligands. For each metal complex, information regarding the tested cell lines and the mechanistic studies will be reported and discussed. The exerted action mechanisms were presented according to the auxiliary ligand/s, the metallic centers, and the increasing complexity of the compound structures.